Social networks
302 6,255Activities
Technologies
Entity types
Location
Magdalen Centre, 1 Robert Robinson Ave, Littlemore, Oxford OX4 4GA, UK
Oxford
United Kingdom
Employees
Scale: 51-200
Estimated: 62
Engaged corporates
6Added in Motherbase
1 year, 3 months agoAdvancing cancer immunotherapy by targeting the unconventional
Enara Bio is shining a light on Dark Antigen® and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients. Our pioneering EDAPT® platform enables us to discover novel cancer-specific antigens from previously uncharted genomic ‘dark matter’. The result is a growing database of Dark Antigens that can address the unmet need for cancer-specific targets that are homogenously expressed and highly prevalent in solid tumors. We are advancing multiple approaches to exploit these Dark Antigen targets, with an internal focus on TCR-directed immunotherapies, and additional therapeutic partnerships with Boehringer Ingelheim and another undisclosed global pharmaceutical company. Based in Oxford, UK, Enara Bio is backed by RA Capital, Samsara Biocapital and SV Health Investors. For more information, please visit: www.enarabio.com
Comments and DMs to this account are not monitored, for any further information please head to our website
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 30 Nov 2023 | | |
![]() United Nations International development, International Affairs | United Nations International development, International Affairs | Other 30 Nov 2023 | | |
![]() UK Research and Innovation Public business cluster, Government Administration | UK Research and Innovation Public business cluster, Government Administration | Other 16 Apr 2021 | | |
![]() Intuitive Medical Device, Medical Equipment Manufacturing | Intuitive Medical Device, Medical Equipment Manufacturing | Other 23 Apr 2021 | | |
![]() AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 26 Jun 2020 | | |
![]() Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 29 Jan 2024 | |